» Articles » PMID: 20186611

Simian Varicella Virus Pathogenesis

Overview
Date 2010 Feb 27
PMID 20186611
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Because varicella zoster virus (VZV) is an exclusively human pathogen, the development of an animal model is necessary to study pathogenesis, latency, and reactivation. The pathological, virological, and immunological features of simian varicella virus (SVV) infection in nonhuman primates are similar to those of VZV infection in humans. Both natural infection of cynomolgus and African green monkeys as well as intrabronchial inoculation of rhesus macaques with SVV provide the most useful models to study viral and immunological aspects of latency and the host immune response. Experimental immunosuppression of monkeys latently infected with SVV results in zoster, thus providing a new model system to study how the loss of adaptive immunity modulates virus reactivation.

Citing Articles

Activation of Interferon-Stimulated Genes following Varicella-Zoster Virus Infection in a Human iPSC-Derived Neuronal In Vitro Model Depends on Exogenous Interferon-α.

Boeren M, Van Breedam E, Buyle-Huybrecht T, Lebrun M, Meysman P, Sadzot-Delvaux C Viruses. 2022; 14(11).

PMID: 36423126 PMC: 9693540. DOI: 10.3390/v14112517.


Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.

Wang W, Pan D, Cheng T, Zhu H Viruses. 2022; 14(5).

PMID: 35632591 PMC: 9144592. DOI: 10.3390/v14050848.


Meningitis/meningoencephalitis caused by varicella zoster virus reactivation: a retrospective single-center case series study.

Yan Y, Yuan Y, Wang J, Zhang Y, Liu H, Zhang Z Am J Transl Res. 2022; 14(1):491-500.

PMID: 35173869 PMC: 8829630.


Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses.

Pinski A, Maroney K, Marzi A, Messaoudi I Emerg Microbes Infect. 2021; 10(1):1320-1330.

PMID: 34112056 PMC: 8253202. DOI: 10.1080/22221751.2021.1942229.


Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.

Wang Y, Qi J, Cao H, Liu C Virol Sin. 2020; 36(1):122-132.

PMID: 32757147 PMC: 7973351. DOI: 10.1007/s12250-020-00261-y.


References
1.
Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin A . Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol. 2001; 75(10):4878-88. PMC: 114242. DOI: 10.1128/JVI.75.10.4878-4888.2001. View

2.
Padovan D, Cantrell C . Varicella-like herpesvirus infections of nonhuman primates. Lab Anim Sci. 1986; 36(1):7-13. View

3.
SOIKE K . Simian varicella virus infection in African and Asian monkeys. The potential for development of antivirals for animal diseases. Ann N Y Acad Sci. 1992; 653:323-33. DOI: 10.1111/j.1749-6632.1992.tb19659.x. View

4.
Gray W, Starnes B, WHITE M, Mahalingam R . The DNA sequence of the simian varicella virus genome. Virology. 2001; 284(1):123-30. DOI: 10.1006/viro.2001.0912. View

5.
Roberts E, Baskin G, Soike K, Gibson S . Pathologic changes of experimental simian varicella (Delta herpesvirus) infection in African green monkeys (Cercopithecus aethiops). Am J Vet Res. 1984; 45(3):523-30. View